Jim Thorn completed his PhD in the field of Medicine at St Bartholomew’s Hospital, University of London in 1991, investigating genetic predisposition to human cardiovascular disease. Following postdoctoral fellowships in the field of membrane transport, Jim joined Beckman Coulter in 1998.
Over the course of 15 years, Jim was responsible for European and Global Capillary Electrophoresis Product Management. In January 2014, Jim joined SCIEX when the CE business from Beckman Coulter was integrated into SCIEX. Jim is now EMEAI Pharma & Biopharma Market Development Team Manager at SCIEX, leading the team responsible for promotion of CE and LC/MS technologies through scientific collaboration.
